Evelo Biosciences, Inc. Gains 46.42%
                        
                                                        Tue, Jun 20, 2023 at 07:39 PM
                        
                    
                
                                            Evelo Biosciences, Inc. (EVLO:NASDAQ) shot up at $0.18, representing a gain of 46.4%. On Tue, Jun 20, 2023, EVLO:NASDAQ hit a New 2-Week High of $0.18. From Tue, Jun 06, 2023, the stock recorded 22.22% Up Days and 0.00% Green Days
The stock spiked on Fri, Jun 16, 2023 at $0.31 with a volume of 161M+.
About Evelo Biosciences, Inc. (EVLO:NASDAQ)
Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.
Top 10 Gainers:
- VCI Global Limited (VCIG:NASDAQ), 156.18%
 - Evelo Biosciences, Inc. (EVLO:NASDAQ), 46.42%
 - Owlet Inc. Class A (OWLT:NYSE), 38%
 - DICE Therapeutics Inc. (DICE:NASDAQ), 37.19%
 - Zura Bio Limited (ZURA:NASDAQ), 35.02%
 - Virgin Galactic Holdings, Inc. (SPCE:NYSE), 27.06%
 - Peak Bio Inc Com (PKBO:NASDAQ), 26.87%
 - MGO Global Inc. (MGOL:NASDAQ), 25.71%
 - Ideanomics, Inc. (IDEX:NASDAQ), 23.82%
 - CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 23.3%